BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Falhammar H, Nordenström A. Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome. Endocrine 2015;50:32-50. [PMID: 26082286 DOI: 10.1007/s12020-015-0656-0] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 7.4] [Reference Citation Analysis]
Number Citing Articles
1 Fouques C, Fatfouta I, Hieronimus S, Sadoul JL, Bongain A. Two cases of male patients followed for a classical form of congenital adrenal hyperplasia (CAH), presenting an azoospermia: analysis and review of the literature. Basic Clin Androl 2019;29:10. [PMID: 31143447 DOI: 10.1186/s12610-019-0084-8] [Reference Citation Analysis]
2 Rushworth RL, Torpy DJ, Falhammar H. Adrenal crises in older patients. Lancet Diabetes Endocrinol 2020;8:628-39. [PMID: 32559478 DOI: 10.1016/S2213-8587(20)30122-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
3 Xu C, Jia W, Cheng X, Ying H, Chen J, Xu J, Guan Q, Zhou X, Zheng D, Li G, Zhao J. Genotype-phenotype correlation study and mutational and hormonal analysis in a Chinese cohort with 21-hydroxylase deficiency. Mol Genet Genomic Med 2019;7:e671. [PMID: 30968594 DOI: 10.1002/mgg3.671] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
4 Falhammar H. Skeletal fragility induced by overtreatment of adrenal insufficiency. Endocrine 2018;59:239-41. [DOI: 10.1007/s12020-017-1501-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
5 Dörr HG, Schulze N, Bettendorf M, Binder G, Bonfig W, Denzer C, Dunstheimer D, Salzgeber K, Schmidt H, Schwab KO, Voss E, Wabitsch M, Wölfle J. Genotype-phenotype correlations in children and adolescents with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Mol Cell Pediatr 2020;7:8. [PMID: 32647925 DOI: 10.1186/s40348-020-00100-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
6 Mazziotti G, Formenti AM, Frara S, Roca E, Mortini P, Berruti A, Giustina A. MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects. Eur J Endocrinol 2017;177:R231-48. [PMID: 28583942 DOI: 10.1530/EJE-17-0154] [Cited by in Crossref: 35] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
7 Lidaka L, Bekere L, Lazdane G, Dzivite-Krisane I, Kivite-Urtane A, Gailite L. Non-Classical Congenital Adrenal Hyperplasia-Causing Alleles in Adolescent Girls with PCOS and in Risk Group for PCOS Development. Diagnostics (Basel) 2021;11:980. [PMID: 34071512 DOI: 10.3390/diagnostics11060980] [Reference Citation Analysis]
8 Concolino P, Costella A. Congenital Adrenal Hyperplasia (CAH) due to 21-Hydroxylase Deficiency: A Comprehensive Focus on 233 Pathogenic Variants of CYP21A2 Gene. Mol Diagn Ther 2018;22:261-80. [DOI: 10.1007/s40291-018-0319-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 7.8] [Reference Citation Analysis]
9 Chatziaggelou A, Sakkas EG, Votino R, Papagianni M, Mastorakos G. Assisted Reproduction in Congenital Adrenal Hyperplasia. Front Endocrinol (Lausanne) 2019;10:723. [PMID: 31708872 DOI: 10.3389/fendo.2019.00723] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
10 Lao Q, Jardin MD, Jayakrishnan R, Ernst M, Merke DP. Complement component 4 variations may influence psychopathology risk in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Hum Genet 2018;137:955-60. [PMID: 30465166 DOI: 10.1007/s00439-018-1959-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
11 Al Alawi AM, Nordenström A, Falhammar H. Clinical perspectives in congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase type 2 deficiency. Endocrine 2019;63:407-21. [PMID: 30719691 DOI: 10.1007/s12020-018-01835-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 8.3] [Reference Citation Analysis]
12 Ekbom K. Pain and Stress Response during Intravenous Access in Children with Congenital Adrenal Hyperplasia: Effects of EMLA and Nitrous Oxide Treatment. Pain Res Treat 2017;2017:1793241. [PMID: 29464120 DOI: 10.1155/2017/1793241] [Reference Citation Analysis]
13 Nordenström A, Svensson J, Lajic S, Frisén L, Nordenskjöld A, Norrby C, Almqvist C, Falhammar H. Carriers of a Classic CYP21A2 Mutation Have Reduced Mortality: A Population-Based National Cohort Study. J Clin Endocrinol Metab 2019;104:6148-54. [PMID: 31393570 DOI: 10.1210/jc.2019-01199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Segev-Becker A, Jacobson R, Stein R, Eyal O, Oren A, Schachter-Davidov A, Israeli G, Lebenthal Y, Weintrob N. WOMEN WITH NONCLASSIC CONGENITAL ADRENAL HYPERPLASIA HAVE GENDER, SEXUALITY, AND QUALITY-OF-LIFE FEATURES SIMILAR TO THOSE OF NONAFFECTED WOMEN. Endocr Pract 2020;26:535-42. [PMID: 31968200 DOI: 10.4158/EP-2019-0509] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
15 Schiffer L, Kempegowda P, Arlt W, O'Reilly MW. MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease. Eur J Endocrinol 2017;177:R125-43. [PMID: 28566439 DOI: 10.1530/EJE-17-0124] [Cited by in Crossref: 50] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
16 Dörr HG, Schulze N, Bettendorf M, Binder G, Bonfig W, Denzer C, Dunstheimer D, Salzgeber K, Schmidt H, Schwab KO, Voss E, Wabitsch M, Wölfle J. Genotyp-Phänotyp-Korrelationen bei Kindern und Jugendlichen mit nichtklassischem adrenogenitalen Syndrom mit 21-Hydroxylase-Defekt. Monatsschr Kinderheilkd. [DOI: 10.1007/s00112-020-00976-y] [Reference Citation Analysis]
17 Corcioni B, Renzulli M, Marasco G, Baronio F, Gambineri A, Ricciardi D, Ortolano R, Farina D, Gaudiano C, Cassio A, Pagotto U, Golfieri R. Prevalence and ultrasound patterns of testicular adrenal rest tumors in adults with congenital adrenal hyperplasia. Transl Androl Urol 2021;10:562-73. [PMID: 33718059 DOI: 10.21037/tau-20-998] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Hannah-Shmouni F, Morissette R, Sinaii N, Elman M, Prezant TR, Chen W, Pulver A, Merke DP. Revisiting the prevalence of nonclassic congenital adrenal hyperplasia in US Ashkenazi Jews and Caucasians. Genet Med 2017;19:1276-9. [PMID: 28541281 DOI: 10.1038/gim.2017.46] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
19 Novello L, Speiser PW. Premature Adrenarche. Pediatr Ann 2018;47:e7-e11. [PMID: 29323690 DOI: 10.3928/19382359-20171214-04] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
20 Espinosa Reyes TM, Collazo Mesa T, Lantigua Cruz PA, Agramonte Machado A, Domínguez Alonso E, Falhammar H. Molecular diagnosis of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. BMC Endocr Disord 2020;20:165. [PMID: 33168061 DOI: 10.1186/s12902-020-00643-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
21 Krysiak R, Drosdzol-Cop A, Skrzypulec-Plinta V, Okopien B. Sexual Function and Depressive Symptoms in Young Women With Nonclassic Congenital Adrenal Hyperplasia. J Sex Med 2016;13:34-9. [PMID: 26755084 DOI: 10.1016/j.jsxm.2015.11.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
22 Asfour H, Baz H, Soliman H, Elshiwy Y, Elsharkawy M, Elmougy F, Morgan M. Mass spectrometry: an essential tool to be used in discrimination between causes of congenital adrenal hyperplasia, and its benefits versus radioimmunoassay. Beni-Suef Univ J Basic Appl Sci 2021;10. [DOI: 10.1186/s43088-021-00132-9] [Reference Citation Analysis]
23 Handelsman DJ, Hirschberg AL, Bermon S. Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance. Endocr Rev 2018;39:803-29. [PMID: 30010735 DOI: 10.1210/er.2018-00020] [Cited by in Crossref: 93] [Cited by in F6Publishing: 74] [Article Influence: 31.0] [Reference Citation Analysis]
24 Conlon TA, Hawkes CP, Brady JJ, Murphy NP. The presentation of congenital adrenal hyperplasia in an unscreened population. J Pediatr Endocrinol Metab 2021;34:1123-9. [PMID: 34167176 DOI: 10.1515/jpem-2021-0123] [Reference Citation Analysis]
25 de Vries L, Lebenthal Y, Phillip M, Shalitin S, Tenenbaum A, Bello R. Obesity and Cardiometabolic Risk Factors in Children and Young Adults With Non-classical 21-Hydroxylase Deficiency. Front Endocrinol (Lausanne) 2019;10:698. [PMID: 31681171 DOI: 10.3389/fendo.2019.00698] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Nordenström A, Lajic S, Falhammar H. Clinical outcomes in 21-hydroxylase deficiency. Curr Opin Endocrinol Diabetes Obes 2021;28:318-24. [PMID: 33741777 DOI: 10.1097/MED.0000000000000625] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
27 Hou B, Jia X, Deng Z, Liu X, Liu H, Yu H, Liu S. Exploration of CYP21A2 and CYP17A1 polymorphisms and preeclampsia risk among Chinese Han population: a large-scale case-control study based on 5021 subjects. Hum Genomics 2020;14:33. [PMID: 32977860 DOI: 10.1186/s40246-020-00286-0] [Reference Citation Analysis]
28 He MN, Zhao SC, Li JM, Tong LL, Fan XZ, Xue YM, Lin XH, Cao Y. Turner syndrome with positive SRY gene and non-classical congenital adrenal hyperplasia: A case report. World J Clin Cases 2021; 9(10): 2259-2267 [PMID: 33869601 DOI: 10.12998/wjcc.v9.i10.2259] [Reference Citation Analysis]
29 Liu K, Motan T, Claman P. No. 350-Hirsutism: Evaluation and Treatment. J Obstet Gynaecol Can 2017;39:1054-68. [PMID: 29080721 DOI: 10.1016/j.jogc.2017.05.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Daae E, Feragen KB, Nermoen I, Falhammar H. Psychological adjustment, quality of life, and self-perceptions of reproductive health in males with congenital adrenal hyperplasia: a systematic review. Endocrine 2018;62:3-13. [PMID: 30128958 DOI: 10.1007/s12020-018-1723-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
31 Hirai H, Kuwana K, Kusano Y. Late onset adrenal insufficiency after adrenalectomy due to latent nonclassical 21-hydroxylase deficiency: A case report. Medicine (Baltimore) 2018;97:e11888. [PMID: 30113485 DOI: 10.1097/MD.0000000000011888] [Reference Citation Analysis]
32 Mackay D, Nordenström A, Falhammar H. Bilateral Adrenalectomy in Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis. The Journal of Clinical Endocrinology & Metabolism 2018;103:1767-78. [DOI: 10.1210/jc.2018-00217] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
33 Livadas S, Bothou C. Management of the Female With Non-classical Congenital Adrenal Hyperplasia (NCCAH): A Patient-Oriented Approach. Front Endocrinol (Lausanne) 2019;10:366. [PMID: 31244776 DOI: 10.3389/fendo.2019.00366] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
34 Falhammar H, Frisén L, Hirschberg AL, Nordenskjöld A, Almqvist C, Nordenström A. Increased Risk of Autoimmune Disorders in 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study. J Endocr Soc 2019;3:1039-52. [PMID: 31065621 DOI: 10.1210/js.2019-00122] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
35 Falhammar H, Torpy DJ. A 42-year-old man presented with adrenal incidentaloma due to non-classic congenital adrenal hyperplasia with a novel CYP21A2 mutation: Letters to the Editor. Intern Med J 2016;46:1115-6. [DOI: 10.1111/imj.13177] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
36 Kawarai Y, Ishikawa H, Segawa T, Teramoto S, Tanaka T, Shozu M. High serum progesterone associated with infertility in a woman with nonclassic congenital adrenal hyperplasia. J Obstet Gynaecol Res 2017;43:946-50. [PMID: 28188961 DOI: 10.1111/jog.13288] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
37 Kocova M, Anastasovska V, Falhammar H. Clinical outcomes and characteristics of P30L mutations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocrine 2020;69:262-77. [PMID: 32367336 DOI: 10.1007/s12020-020-02323-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
38 Suchartlikitwong S, Jasti R, Lado-Abeal J, Rivas Mejia AM. Bilateral adrenal myelolipomas presenting as acute adrenal insufficiency in an adult with congenital adrenal hyperplasia. BMJ Case Rep 2019;12:bcr-2018-226826. [PMID: 30739087 DOI: 10.1136/bcr-2018-226826] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
39 Falhammar H, Frisén L, Norrby C, Almqvist C, Hirschberg AL, Nordenskjöld A, Nordenström A. Reduced Frequency of Biological and Increased Frequency of Adopted Children in Males With 21-Hydroxylase Deficiency: A Swedish Population-Based National Cohort Study. The Journal of Clinical Endocrinology & Metabolism 2017;102:4191-9. [DOI: 10.1210/jc.2017-01139] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
40 Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, Merke DP, Meyer-Bahlburg HFL, Miller WL, Murad MH, Oberfield SE, White PC. Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2018;103:4043-88. [PMID: 30272171 DOI: 10.1210/jc.2018-01865] [Cited by in Crossref: 272] [Cited by in F6Publishing: 224] [Article Influence: 90.7] [Reference Citation Analysis]
41 Kurtoğlu S, Hatipoğlu N. Non-Classical Congenital Adrenal Hyperplasia in Childhood. J Clin Res Pediatr Endocrinol 2017;9:1-7. [PMID: 27354284 DOI: 10.4274/jcrpe.3378] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
42 Chrisp GL, Maguire AM, Quartararo M, Falhammar H, King BR, Munns CF, Torpy DJ, Hameed S, Rushworth RL. Variations in the management of acute illness in children with congenital adrenal hyperplasia: An audit of three paediatric hospitals. Clin Endocrinol (Oxf) 2018;89:577-85. [PMID: 30086199 DOI: 10.1111/cen.13826] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
43 Garito T, Zakaria M, Papanicolaou DA, Li Y, Pinot P, Petricoul O, Laurent D, Rooks D, Rondon JC, Roubenoff R. Effects of bimagrumab, an activin receptor type II inhibitor, on pituitary neurohormonal axes. Clin Endocrinol (Oxf) 2018;88:908-19. [PMID: 29566437 DOI: 10.1111/cen.13601] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
44 Nordenström A, Butwicka A, Lindén Hirschberg A, Almqvist C, Nordenskjöld A, Falhammar H, Frisén L. Are carriers of CYP21A2 mutations less vulnerable to psychological stress? A population-based national cohort study. Clin Endocrinol (Oxf) 2017;86:317-24. [PMID: 27654981 DOI: 10.1111/cen.13242] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
45 Bulsari K, Falhammar H. Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Endocrine 2017;55:19-36. [DOI: 10.1007/s12020-016-1189-x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 37] [Article Influence: 7.7] [Reference Citation Analysis]